[Inflammatory myofibroblastic genitourinary tumor: The challenge of controlling and monitoring an non frequent oncological disease]

Arch Esp Urol. 2017 Mar;70(2):306-310.
[Article in Spanish]

Abstract

Objective: The inflammatory myofibroblastic tumor (IMT) is a neoplasia with intermediate biological potential, infrequent, with an unpredictable clinical prognosis and a low recurrence rate after an effective treatment. We report two cases of IMT with genitourinary localization, being this entit's publications infrequent. Both presented with little symptomatology, leading to multiple differential diagnosis. The surgical treatment was chosen and pathologic result confirmed the diagnosis.

Conclusion: This entity must be considered as a true malignant neoplasm with aggressive local behavior. The gold standard management is complete surgical resection, with low recurrence rate after it. A new oncological monitoring scheme is proposed, upon the lack of an active surveillance algorithm after treatment.

Publication types

  • Case Reports

MeSH terms

  • Algorithms
  • Genital Neoplasms, Male* / diagnosis
  • Genital Neoplasms, Male* / therapy
  • Granuloma, Plasma Cell* / diagnosis
  • Granuloma, Plasma Cell* / therapy
  • Humans
  • Male
  • Middle Aged
  • Retroperitoneal Neoplasms* / diagnosis
  • Retroperitoneal Neoplasms* / therapy
  • Spermatic Cord*